WallStreetZenWallStreetZen

NASDAQ: RADX
Radiopharm Theranostics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Radiopharm Theranostics revenue was $2.37M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, RADX annual revenue was $2.4M, with 1,098.3% growth year-over-year.

RADX past revenue growth

How has RADX's revenue growth performed historically?

Company
1,098.29%
Industry
145.48%
Market
16.87%
RADX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RADX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RADX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RADX revenue history

Current Revenue
$2.4M
Current Earnings
-$24.1M
Current Profit Margin
-1,010.2%

Be the first to know when RADX announces revenue.

RADX Revenue History By Year

RADX Yearly RevenueRADX RevenueRADX ChangeRADX Revenue Growth
2025-06-30$2.39M$2.19M+1,098.29%
2024-06-30$199.49k-$2.14k-1.06%
2023-06-30$201.63kN/AN/A
2022-06-30$0.00N/AN/A

1 of 1

Radiopharm Theranostics Revenue FAQ

What was RADX's revenue last quarter?

On Invalid Date, Radiopharm Theranostics (NASDAQ: RADX) reported Q2 2025 revenue of N/A up N/A year over year. In the same quarter last year, Radiopharm Theranostics's revenue was N/A.

What was Radiopharm Theranostics's revenue in 2025?

Radiopharm Theranostics's annual revenue for the twelve months ending Jun 30, 2025 was $2.39 million, a 1,098.29% increase year over year.

How much does Radiopharm Theranostics make in a day?

Based on Radiopharm Theranostics annual revenue for the past three years, RADX makes an average of $2,549.33 per day.

What was Radiopharm Theranostics's annual revenue growth in the past year?

As of Q3 2025, Radiopharm Theranostics's revenue has grown 1,098.29% year over year. This is 952.81 percentage points higher than the US Biotechnology industry revenue growth rate of 145.48%. Radiopharm Theranostics's revenue in the past year totaled $2.37 million.

How much does Radiopharm Theranostics make in a year?

Radiopharm Theranostics's revenue by year for the past three years is:
  • Radiopharm Theranostics's revenue for the twelve months ending Jun 30, 2025 was $2.39 million, a 1,098.29% increase year over year.
  • Radiopharm Theranostics's annual revenue for Jun 30, 2024 was $199.49 thousand, a 1.06% decrease from 2023.
  • Radiopharm Theranostics's annual revenue for 2023 was $201.63 thousand, a Infinity% increase from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.